• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR®XM DISTAL CENTRALIZER; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. PROFEMUR®XM DISTAL CENTRALIZER; HIP COMPONENT Back to Search Results
Model Number PRXMDC01
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Insufficient Information (4580)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Event or Problem Description
Allegedly, patient was revised due to dislocation/subluxation.Srnjr number: (b)(6).Side: r.Gender: f.
 
Additional Manufacturer Narrative
The alleged complaint could not be confirmed.Review of the complaint does not reveal any failure involving this implant.Mpo was made aware of this incident through the united kingdom national joint registry.The revised products were not returned, and no explant images, radiographs, operative notes, or other clinically relevant documentation is available for review to confirm this occurrence.This implant was implanted in a 80 yo female patient for approximately 1 month before revision due to dislocation was required.These lots were manufactured in 2020 (pha04408), 2022 (pha060e0), and 2024 (ppec0l32, ppamq048, prxmdc01).Review of the design history record (dhr) for the subject manufacturing lots indicate that these implants were manufactured to specification.There are no trends for these implants and failure.Dislocation is one of the most common complications of total hip arthroplasty and can be influenced by both patient and/or surgical factors such as implant choice, technique, implant alignment, and tissue laxity.The microport hip systems package insert (150803-9) lists ?dislocation, migration and/or subluxation of prosthetic components from improper positioning, trauma, loss of fixation and/or muscle and fibrous tissue laxity? as a potential adverse effect of total hip arthroplasty.Without additional details, no conclusions can be drawn.Mpo will continue to monitor for complaint trends.Methods: analysis of production records (3331).Device not returned (4114).Trend analysis (4110).Results: no findings available (3221).Conclusions: device met specification.Device was used for treatment.Known inherent risk of device (22).Cause not established (4315).Correct type of reportable event: serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROFEMUR®XM DISTAL CENTRALIZER
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
Manufacturer Contact
rachael wise
5677 airline road
arlington, TN 38002
9018674771
MDR Report Key21209903
Report Number3010536692-2025-00010
Device Sequence Number3943192
Product Code LPH
UDI-Device IdentifierM684PRXMDC011
UDI-PublicM684PRXMDC011
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K052915
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/26/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberPRXMDC01
Device Catalogue NumberPRXMDC01
Device Lot Number2024928
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/24/2024
Supplement Date Received by ManufacturerNot provided
Not provided
Initial Report FDA Received Date01/22/2025
Supplement Report FDA Received Date10/30/2025
11/26/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
Patient SexFemale
-
-